A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer: an Alliance Foundation trial (AFT-19)
- Citation:
- J Clin Oncol vol 36 (15_suppl) abstr TPS5090
- Meeting Instance:
- ASCO 2018
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- AFT
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epreprint
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Rahul Aggarwal Scott Eggener Ronald Chen Glenn Heller Akash Patnaik Han Xiao Douglas Weckstein James Mohler Mark Watson Mary-Ellen Taplin Linda Skoog-Sluman Meryl Pereji Eunice Aikins-Afful John Kellogg Parsons Charles J. Ryan Michael M. Morris
- Networks:
- CA249, CA824, KANSAS, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY016, LAPS-NY158, MN022, NH038
- Study
- AFT-19
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: